ATE132136T1 - Antitumor anthracenderivate - Google Patents

Antitumor anthracenderivate

Info

Publication number
ATE132136T1
ATE132136T1 AT92907670T AT92907670T ATE132136T1 AT E132136 T1 ATE132136 T1 AT E132136T1 AT 92907670 T AT92907670 T AT 92907670T AT 92907670 T AT92907670 T AT 92907670T AT E132136 T1 ATE132136 T1 AT E132136T1
Authority
AT
Austria
Prior art keywords
pct
nitrogen atom
hydroxy
group
separately selected
Prior art date
Application number
AT92907670T
Other languages
English (en)
Inventor
Laurence Hylton Fare Patterson
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of ATE132136T1 publication Critical patent/ATE132136T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C07C291/04—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/50—Nitrogen atoms bound to hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT92907670T 1991-04-12 1992-04-10 Antitumor anthracenderivate ATE132136T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919107843A GB9107843D0 (en) 1991-04-12 1991-04-12 Anti-cancer compounds

Publications (1)

Publication Number Publication Date
ATE132136T1 true ATE132136T1 (de) 1996-01-15

Family

ID=10693185

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907670T ATE132136T1 (de) 1991-04-12 1992-04-10 Antitumor anthracenderivate

Country Status (11)

Country Link
US (1) US5461078A (de)
EP (1) EP0579646B1 (de)
JP (1) JPH06506923A (de)
AT (1) ATE132136T1 (de)
AU (1) AU660883B2 (de)
CA (1) CA2108256A1 (de)
DE (1) DE69207182T2 (de)
ES (1) ES2082461T3 (de)
GB (2) GB9107843D0 (de)
WO (1) WO1992018469A1 (de)
ZA (1) ZA922641B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107852D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
US6277985B1 (en) * 1995-09-15 2001-08-21 Pharmacia & Upjohn Company Aminoaryl oxazolidinone N-oxides
JP2002507557A (ja) * 1998-03-26 2002-03-12 デパートメント オブ ジ アーミー， ユー．エス． ガバメント 抗生物質抵抗性感染の処置のための置換芳香族化合物
RU2349311C1 (ru) * 2007-08-02 2009-03-20 Михаил Владимирович Кутушов Применение дериватов нафталина в качестве средств для лечения онкологических заболеваний
WO2014062856A1 (en) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
CN107056623A (zh) * 2017-05-02 2017-08-18 南京安琪儿生物科技有限公司 一种蓝色溶酶体标记荧光染料的合成新方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1118414A (fr) * 1953-06-19 1956-06-06 Yoshitomi Pharmaceutical Procédé de préparation des nu-oxydes d'amines tertiaires aliphatiques halogénées
GB781237A (en) * 1954-12-14 1957-08-14 Sterling Drug Inc Anthracene derivatives and their preparation
FR1316453A (fr) * 1958-07-05 1963-02-01 Parke Davis & Co Procédé de fabrication de composés acridinylamino-o-crésol, 10-oxyde
US3174994A (en) * 1962-01-30 1965-03-23 Smith Kline French Lab Hypocholesterolemic n-oxide compositions
FR1505351A (fr) * 1966-01-06 1967-12-15 Rhone Poulenc Sa Nouveaux dérivés de l'anthracène et leur préparation
CH517096A (de) * 1968-08-31 1971-12-31 Starogardzkie Zakl Farma Verfahren zur Herstellung neuer, biologisch aktiver 1-Nitro-9-(dialkyl-aminoalkylamino)-akridin-N10-oxide
IL69211A (en) * 1982-07-23 1987-01-30 Warner Lambert Co Substituted anthra(1,9-cd)pyrazol-6(2h)-ones,their preparation and pharmaceutical compositions containing them
US4555572A (en) * 1983-07-19 1985-11-26 Warner-Lambert Company Pyrazolo[3,4,5-kl]acridine compositions and methods for their production and use
US4626540A (en) * 1983-11-08 1986-12-02 Warner-Lambert Company Substituted 1-amino-4-nitro-acridinones and methods of treating bacterial infections and leukemia with them
DE3405330A1 (de) * 1984-02-15 1985-08-22 Sandoz-Patent-GmbH, 7850 Lörrach Neue allylamine, verfahren zu ihrer herstellung und ihre verwendung
US4686218A (en) * 1985-01-30 1987-08-11 Smithkline Beckman Corporation Use of 6-chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepine-n-oxide, as a prodrug
IN164921B (de) * 1986-07-22 1989-07-08 Hoechst India
GB8923075D0 (en) * 1989-10-13 1989-11-29 Patterson Laurence H Anti-cancer compounds
US4963554A (en) * 1990-02-14 1990-10-16 Ortho Pharmaceutical Corporation 6,7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides

Also Published As

Publication number Publication date
GB2254613B (en) 1995-01-25
GB9207957D0 (en) 1992-05-27
WO1992018469A1 (en) 1992-10-29
EP0579646A1 (de) 1994-01-26
JPH06506923A (ja) 1994-08-04
GB9107843D0 (en) 1991-05-29
ZA922641B (en) 1993-10-11
US5461078A (en) 1995-10-24
AU660883B2 (en) 1995-07-06
DE69207182T2 (de) 1996-05-15
DE69207182D1 (en) 1996-02-08
EP0579646B1 (de) 1995-12-27
GB2254613A (en) 1992-10-14
CA2108256A1 (en) 1992-10-13
AU1537692A (en) 1992-11-17
ES2082461T3 (es) 1996-03-16

Similar Documents

Publication Publication Date Title
ATE101181T1 (de) Anti-krebs-verbindungen.
MY108261A (en) Water soluble camptothecin derivatives
PT1140851E (pt) 4-oxo-1,4-di-hidro-3-quinolinacarboxamidas como agentes antivirais
KR950700278A (ko) 벤조사이클로헵텐, 벤조옥세핀 및 벤조티에핀(benzocycloheptenes, benzoxepines and benzothiepines)
FI900461A0 (fi) Imidazopyridaziner, deras framstaellning och anvaendning.
DE69207182T2 (de) Antitumor anthracenderivate
DK0591058T3 (da) Ellipticinderivater med antitumoraktivitet
ATE83776T1 (de) 1,2-benzisoxazole und 1,2-benzisothiazole.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee